Judge Clears Medical Groups to Challenge Kennedy Vaccine Policy Changes

A U.S. District Court judge in Boston on Jan. 6 ruled that several prominent medical organizations may proceed with their lawsuit challenging vaccine-policy changes implemented under Health Secretary Robert F. Kennedy Jr. U.S. District Judge Brian Murphy rejected the government’s contention that the groups lacked legal standing, permitting the case to move beyond an early threshold motion and onto the merits.

Plaintiffs named in the suit include the American Academy of Pediatrics, the American College of Physicians, the American Public Health Association, and the Infectious Diseases Society of America. The organizations filed the original complaint in July and have since expanded the list of plaintiffs as the case has developed.

The complaint alleges that a series of actions by Secretary Kennedy and the Centers for Disease Control and Prevention will depress vaccination rates and undermine public health. Central to the suit are two claims: that in May the secretary directed the CDC to remove its recommendation for COVID-19 vaccination for pregnant women and children from the agency’s official vaccination schedules, and that in June he dismissed 17 independent experts from the Advisory Committee on Immunization Practices, or ACIP, replacing them with members who largely align with his views.

Those personnel and procedural changes, the plaintiffs contend, tainted subsequent ACIP votes and impaired the integrity of CDC vaccine guidance. Among the remedies sought by the medical groups is an order invalidating ACIP votes taken since the June replacements. During a Dec. 17 hearing, lawyers for the plaintiffs told Judge Murphy they would seek expedited relief if the court allowed the case to proceed, with an eye toward the panel’s next scheduled meeting on Feb. 25–26.

Lawyers for the administration argued in court that the organizations could not show a concrete injury necessary to establish standing. Judge Murphy found otherwise, concluding the plaintiffs had demonstrated sufficient interest and potential harm to pursue their claims in federal court. The ruling keeps the litigation in the U.S. District Court in Boston and sets the schedule for further briefing and potential emergency motions.

ACIP is the CDC’s formal advisory committee on vaccine policy and routinely votes on recommendations that influence clinical practice and public health programs. A court decision on the validity of its recent votes could have immediate operational effects on CDC guidance and longer-term implications for how advisory committees are constituted and overseen.

Public health experts and the medical organizations say the stakes include possible declines in vaccination coverage, confusion among clinicians and patients, and erosion of trust in public health institutions. The Justice Department, representing the administration, has not yet indicated whether it will seek immediate appellate review of Judge Murphy’s standing ruling.

With the Feb. 25–26 ACIP meeting approaching, the next weeks are likely to be crowded with court filings as the plaintiffs seek expedited relief and the government prepares its defense. The outcome will determine not only the fate of recent ACIP votes but also the legal contours governing the relationship between agency advisory bodies and political leadership.